Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 5 July 2021
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 5 July 2021. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share (excluding Revaluation Surplus) was Tk. 70.79 as on March 31, 2021 and Tk. 68.69 as on June 31, 2020. NAV per share (including Revaluation Surplus) was Tk. 78.78 as on March 31, 2021 and Tk. 76.77 as on June 31, 2020. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400530e3
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.